Ulysses Management LLC Moderna, Inc. Transaction History

Ulysses Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $604,350 - $818,703	5,100 New	5,100 $619,000
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $355,140 - $630,120	-3,000 Reduced 33.33%	6,000 $1.08 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $1.06 Million - $1.75 Million	9,000 New	9,000 $1.06 Million

953

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Ulysses Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ulysses Management LLC with notifications on news.